The announcement Wednesday is the second overseas acquisition in two months by Piramal.
Piramal agreed in April to buy a portfolio of medical imaging molecules from Germany's Bayer Pharma including an Alzheimer's diagnosis it says could yield $1.5 billion in revenue.
Decision Resources Group, based in Burlington, Massachusetts, provides research and analysis to pharmaceutical companies. It projects revenue this year will be $160 million.
trisomy wwe royal rumble leon panetta luck sag awards 2012 nominees sag awards pro bowl 2012 roster
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.